Hydrocodone-containing products becoming Schedule II drugs
The Drug Enforcement Agency (DEA) has put into place new requirements for hydrocodone-containing products (HCPs). Effective October 6, 2014, all HCPs will become Schedule II drugs. Currently, some HCPs are Schedule II controlled drugs and some fall under Schedule III. HCPs are used in veterinary hospitals to help control coughing in dogs and to manage pain.
For prescribers, a new prescription will be required for all hydrocodone products prescribed after October 5, 2014. No refills will be allowed, similar to other Schedule II drugs. The DEA will allow pharmacies to dispense HCP refills on prescriptions if the prescription was issued prior to October 6, 2014 and the dispensing refill occurs before the expiration date, not to exceed April 8, 2015. All DEA registrants will have to use official DEA Form 222c to order or transfer any hydrocodone products, rather than simple invoices or packing slips. As with all Schedule II – V controlled drugs, dispensing of greater than 14 days’ supply must be reported to the Prescription Drug Monitoring Program.
The mission of the ACT is to promote animal well-being, reproductive health, responsible breeding and genetic practices, and efficient management of breeding-age animals in agriculture, veterinary practice, zoos, preserves, and ecosystems. In particular, the ACT envisions development of focus areas in theriogenology to incorporate the following in theriogenology/reproductive medicine:
1. Population control for domestic and non-domestic animals including feral animals, free-ranging and captive wildlife.
2. Genomics in livestock and companion animal practice.
American College of Theriogenologists
761 Tiger Oak Drive
Pike Road, AL 36064-3060